speb/financial-data huggingface dataset:
IRIX balance_sheet (annual, 2024-12-31) — Long Term Debt: 1004000.00
IRIX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1815000.00
IRIX cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -218000.00
IRIX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 3370000.00
IRIX cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
IRIX balance_sheet (annual, 2024-12-31) — Net Debt: 351000.00
IRIX balance_sheet (quarterly, 2024-12-31) — Net Debt: 351000.00
IRIX income_statement (annual, 2024-12-31) — Net Income: -8910000.00
IRIX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -8910000.00
IRIX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -8910000.00
IRIX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -8910000.00
IRIX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -8910000.00
IRIX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -8910000.00
IRIX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -8910000.00
IRIX cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -218000.00
IRIX cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -218000.00
IRIX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -551000.00
IRIX cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 0.00
IRIX balance_sheet (annual, 2024-12-31) — Net PPE: 1907000.00
IRIX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -13000.00
IRIX cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
IRIX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -174000.00
IRIX balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 8350000.00
IRIX balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 8350000.00
IRIX income_statement (annual, 2024-12-31) — Normalized EBITDA: -6878000.00
IRIX income_statement (annual, 2024-12-31) — Normalized Income: -8910000.00
IRIX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -7285000.00
IRIX income_statement (annual, 2024-12-31) — Operating Income: -8302000.00
IRIX income_statement (annual, 2024-12-31) — Operating Revenue: 48669000.00
IRIX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 16636380.00
IRIX balance_sheet (annual, 2024-12-31) — Other Current Assets: 1964000.00
IRIX balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 1734000.00
IRIX balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 1734000.00
IRIX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 51000.00
IRIX income_statement (annual, 2024-12-31) — Other Gand A: 9776000.00
IRIX income_statement (annual, 2024-12-31) — Other Income Expense: -540000.00
IRIX balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 1306000.00
IRIX cash_flow (annual, 2024-12-31) — Other Non Cash Items: 328000.00
IRIX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1394000.00
IRIX balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 314000.00
IRIX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -540000.00
IRIX balance_sheet (annual, 2024-12-31) — Other Payable: 57000.00
IRIX balance_sheet (quarterly, 2024-12-31) — Other Payable: 57000.00
IRIX balance_sheet (annual, 2024-12-31) — Other Properties: 13396000.00
IRIX balance_sheet (annual, 2024-12-31) — Payables: 7801000.00
IRIX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 8571000.00
IRIX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1672000.00
IRIX balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
IRIX balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
IRIX cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
IRIX income_statement (annual, 2024-12-31) — Pretax Income: -8842000.00
IRIX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 4000.00
IRIX cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
IRIX balance_sheet (annual, 2024-12-31) — Properties: 0.00
IRIX balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
IRIX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -13000.00
IRIX balance_sheet (annual, 2024-12-31) — Raw Materials: 4236000.00
IRIX balance_sheet (annual, 2024-12-31) — Receivables: 8394000.00
IRIX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 29167000.00
IRIX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1424000.00
IRIX cash_flow (annual, 2024-12-31) — Repayment Of Debt: -218000.00
IRIX income_statement (annual, 2024-12-31) — Research And Development: 5449000.00
IRIX balance_sheet (annual, 2024-12-31) — Retained Earnings: -88009000.00
IRIX income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 12579000.00
IRIX income_statement (annual, 2024-12-31) — Selling General And Administration: 22355000.00
IRIX balance_sheet (annual, 2024-12-31) — Share Issued: 16636380.00
IRIX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1243000.00
IRIX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 2097000.00
IRIX balance_sheet (annual, 2024-12-31) — Tangible Book Value: -174000.00
IRIX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
IRIX income_statement (annual, 2024-12-31) — Tax Provision: 68000.00
IRIX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
IRIX balance_sheet (annual, 2024-12-31) — Total Assets: 29135000.00
IRIX balance_sheet (annual, 2024-12-31) — Total Capitalization: 3101000.00
IRIX balance_sheet (annual, 2024-12-31) — Total Debt: 4643000.00
IRIX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 2097000.00
IRIX income_statement (annual, 2024-12-31) — Total Expenses: 56971000.00
IRIX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 27038000.00
IRIX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 5572000.00
IRIX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 10479000.00
IRIX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -8302000.00
IRIX balance_sheet (annual, 2024-12-31) — Total Tax Payable: 150000.00
IRIX balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 150000.00
IRIX balance_sheet (annual, 2024-12-31) — Work In Process: 0.00
IRIX balance_sheet (quarterly, 2024-12-31) — Work In Process: 0.00
IRIX balance_sheet (annual, 2024-12-31) — Working Capital: 7003000.00
IRIX income_statement (quarterly, 2025-03-31) — +Operating Expense: 5260000.00
IRIX income_statement (quarterly, 2025-03-31) — +Total Revenue: 11896000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 6048000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 6680000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 90344000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -112000.00
IRIX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 16727000.00
IRIX income_statement (quarterly, 2025-03-31) — Basic EPS: -0.10
IRIX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 2387000.00
IRIX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -11000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1655000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 174000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 7244000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 7244000.00
IRIX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 6039000.00
IRIX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -11000.00
IRIX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1149000.00
IRIX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -1291000.00
IRIX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 835000.00
IRIX cash_flow (quarterly, 2025-03-31) — Change In Inventory: 675000.00
IRIX cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 96000.00
IRIX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -41000.00
IRIX cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -468000.00
IRIX cash_flow (quarterly, 2025-03-31) — Change In Payable: -1240000.00
IRIX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -405000.00
IRIX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -393000.00
IRIX cash_flow (quarterly, 2025-03-31) — Change In Receivables: -992000.00
IRIX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1528000.00
IRIX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -729000.00
IRIX cash_flow (quarterly, 2025-03-31) — Changes In Cash: 4879000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Common Stock: 174000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 852000.00
IRIX income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 6841000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 969000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Current Assets: 29129000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1120000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1120000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 2090000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 2090000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 14947000.00
IRIX cash_flow (quarterly, 2025-03-31) — Depreciation: 381000.00
IRIX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 381000.00
IRIX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 381000.00
IRIX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 16727000.00
IRIX income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.10
IRIX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1686000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 2706000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 660000.00
IRIX income_statement (quarterly, 2025-03-31) — EBIT: -205000.00
IRIX income_statement (quarterly, 2025-03-31) — EBITDA: 176000.00
IRIX cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -22000.00
IRIX cash_flow (quarterly, 2025-03-31) — End Cash Position: 7244000.00
IRIX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 6039000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Finished Goods: 6294000.00
IRIX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1160000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 29000.00
IRIX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1931000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Goodwill: 965000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2188000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 6792000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1621000.00
IRIX income_statement (quarterly, 2025-03-31) — Gross Profit: 5055000.00
IRIX cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 24000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Inventory: 10142000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 4496000.00
IRIX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -11000.00
IRIX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 6000000.00
IRIX cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 4000000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 535000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 3644000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 4179000.00
IRIX cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 4000000.00
IRIX cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -3961000.00
IRIX income_statement (quarterly, 2025-03-31) — Net Income: -1686000.00
IRIX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1686000.00
IRIX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1686000.00
IRIX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1686000.00
IRIX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1686000.00
IRIX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -1686000.00
IRIX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1686000.00
IRIX cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 39000.00
IRIX cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 39000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Net PPE: 1621000.00
IRIX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -11000.00
IRIX cash_flow (quarterly, 2025-03-31) — Net Preferred Stock Issuance: 6000000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -1336000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 7968000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 7968000.00
IRIX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 176000.00
IRIX income_statement (quarterly, 2025-03-31) — Normalized Income: -1686000.00
IRIX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1149000.00
IRIX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 1335000.00
IRIX income_statement (quarterly, 2025-03-31) — Operating Income: -205000.00
IRIX income_statement (quarterly, 2025-03-31) — Operating Revenue: 11896000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 16789027.00
IRIX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2357000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 2045000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 29000.00
IRIX income_statement (quarterly, 2025-03-31) — Other Gand A: 1931000.00
IRIX income_statement (quarterly, 2025-03-31) — Other Income Expense: -1469000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1223000.00
IRIX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 136000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1298000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 290000.00
IRIX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -1469000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Other Properties: 1621000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Payables: 6708000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 7677000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2015000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Preferred Securities Outside Stock Equity: 6000000.00
IRIX cash_flow (quarterly, 2025-03-31) — Preferred Stock Issuance: 6000000.00
IRIX income_statement (quarterly, 2025-03-31) — Pretax Income: -1674000.00
IRIX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -11000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Raw Materials: 3848000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Receivables: 9386000.00
IRIX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 6841000.00
IRIX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 381000.00
IRIX cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -3961000.00
IRIX income_statement (quarterly, 2025-03-31) — Research And Development: 876000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -89695000.00
IRIX income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 2453000.00
IRIX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 4384000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Share Issued: 16789027.00
IRIX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 213000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 852000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -1336000.00
IRIX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IRIX income_statement (quarterly, 2025-03-31) — Tax Provision: 12000.00
IRIX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
IRIX balance_sheet (quarterly, 2025-03-31) — Total Assets: 34236000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4496000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Total Debt: 5299000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 852000.00
IRIX income_statement (quarterly, 2025-03-31) — Total Expenses: 12101000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 33384000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 5107000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 18437000.00
IRIX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -205000.00
IRIX balance_sheet (quarterly, 2025-03-31) — Work In Process: 0.00
IRIX balance_sheet (quarterly, 2025-03-31) — Working Capital: 14182000.00
IRIX income_statement (quarterly, 2025-06-30) — +Operating Expense: 5622000.00
IRIX income_statement (quarterly, 2025-06-30) — +Total Revenue: 13571000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 5314000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 7137000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 90587000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -112000.00
IRIX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 16793000.00
IRIX income_statement (quarterly, 2025-06-30) — Basic EPS: -0.06
IRIX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 7244000.00
IRIX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -13000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 1393000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 6174000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 6778000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 6778000.00
IRIX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -14000.00
IRIX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -13000.00
IRIX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -397000.00
IRIX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -734000.00
IRIX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -539000.00
IRIX cash_flow (quarterly, 2025-06-30) — Change In Inventory: 1707000.00
IRIX cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 25000.00
IRIX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -189000.00
IRIX cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -202000.00
IRIX cash_flow (quarterly, 2025-06-30) — Change In Payable: -959000.00
IRIX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -1498000.00
IRIX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 732000.00
IRIX cash_flow (quarterly, 2025-06-30) — Change In Receivables: -644000.00
IRIX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -69000.00
IRIX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -457000.00
IRIX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -424000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Common Stock: 174000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 59000.00
IRIX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 8889000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 584000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Current Assets: 26868000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1145000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1145000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 2269000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 2269000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 13709000.00
IRIX cash_flow (quarterly, 2025-06-30) — Depreciation: 378000.00
IRIX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 378000.00
IRIX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 378000.00
IRIX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 16793000.00
IRIX income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.06
IRIX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -994000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 2893000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 435000.00
IRIX income_statement (quarterly, 2025-06-30) — EBIT: -940000.00
IRIX income_statement (quarterly, 2025-06-30) — EBITDA: -562000.00
IRIX cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -42000.00
IRIX cash_flow (quarterly, 2025-06-30) — End Cash Position: 6778000.00
IRIX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -14000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Finished Goods: 4675000.00
IRIX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -410000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -13000.00
IRIX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2216000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Goodwill: 965000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 2109000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 7249000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1335000.00
IRIX income_statement (quarterly, 2025-06-30) — Gross Profit: 4682000.00
IRIX cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 0.00
IRIX balance_sheet (quarterly, 2025-06-30) — Inventory: 8435000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 3734000.00
IRIX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -13000.00
IRIX cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
IRIX cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
IRIX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 248000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 3675000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 3923000.00
IRIX cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
IRIX cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 0.00
IRIX income_statement (quarterly, 2025-06-30) — Net Income: -994000.00
IRIX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -994000.00
IRIX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -994000.00
IRIX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -994000.00
IRIX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -994000.00
IRIX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -994000.00
IRIX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -994000.00
IRIX cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
IRIX cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
IRIX balance_sheet (quarterly, 2025-06-30) — Net PPE: 1335000.00
IRIX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -13000.00
IRIX cash_flow (quarterly, 2025-06-30) — Net Preferred Stock Issuance: 0.00
IRIX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 3950000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 7587000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 7587000.00
IRIX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -562000.00
IRIX income_statement (quarterly, 2025-06-30) — Normalized Income: -994000.00
IRIX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -397000.00
IRIX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 0.00
IRIX income_statement (quarterly, 2025-06-30) — Operating Income: -940000.00
IRIX income_statement (quarterly, 2025-06-30) — Operating Revenue: 11341000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 16814713.00
IRIX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1625000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 2101000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -13000.00
IRIX income_statement (quarterly, 2025-06-30) — Other Gand A: 2216000.00
IRIX income_statement (quarterly, 2025-06-30) — Other Income Expense: -33000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1144000.00
IRIX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 31000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1273000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 307000.00
IRIX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -33000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Other Properties: 1335000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Payables: 5749000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 6333000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 1861000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 6000000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 6000000.00
IRIX cash_flow (quarterly, 2025-06-30) — Preferred Stock Issuance: 0.00
IRIX income_statement (quarterly, 2025-06-30) — Pretax Income: -973000.00
IRIX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -13000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Raw Materials: 3760000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Receivables: 10030000.00
IRIX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 8889000.00
IRIX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 378000.00
IRIX cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 0.00
IRIX income_statement (quarterly, 2025-06-30) — Research And Development: 871000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -90689000.00
IRIX income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 2535000.00
IRIX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 4751000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Share Issued: 16814713.00
IRIX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 257000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 6059000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -2050000.00
IRIX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
IRIX income_statement (quarterly, 2025-06-30) — Tax Provision: 21000.00
IRIX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
IRIX balance_sheet (quarterly, 2025-06-30) — Total Assets: 31585000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 9734000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Total Debt: 5068000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 6059000.00
IRIX income_statement (quarterly, 2025-06-30) — Total Expenses: 14511000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 25526000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 4717000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 11817000.00
IRIX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -940000.00
IRIX balance_sheet (quarterly, 2025-06-30) — Working Capital: 13159000.00
IRIX income_statement (quarterly, 2025-09-30) — +Operating Expense: 5424000.00
IRIX income_statement (quarterly, 2025-09-30) — +Total Revenue: 12484000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 4409000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 7132000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 90782000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -112000.00
IRIX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 17009000.00
IRIX income_statement (quarterly, 2025-09-30) — Basic EPS: -0.09
IRIX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 6778000.00
IRIX cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -13000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1080000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 6174000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 5573000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 5573000.00
IRIX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -34000.00
IRIX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -13000.00
IRIX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -1158000.00
IRIX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -905000.00
IRIX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 79000.00
IRIX cash_flow (quarterly, 2025-09-30) — Change In Inventory: 311000.00
IRIX cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 77000.00
IRIX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -259000.00
IRIX cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -440000.00
IRIX cash_flow (quarterly, 2025-09-30) — Change In Payable: -1127000.00
IRIX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -1048000.00
IRIX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -37000.00
IRIX cash_flow (quarterly, 2025-09-30) — Change In Receivables: 500000.00
IRIX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -896000.00
IRIX cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 5000.00
IRIX cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1205000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Common Stock: 174000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -1319000.00
IRIX income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 8471000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 592000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Current Assets: 24066000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1028000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1028000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 2208000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 2208000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 12392000.00
IRIX cash_flow (quarterly, 2025-09-30) — Depreciation: 366000.00
IRIX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 366000.00
IRIX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 366000.00
IRIX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 17009000.00
IRIX income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.09
IRIX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -1573000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 2398000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 213000.00
IRIX income_statement (quarterly, 2025-09-30) — EBIT: -1411000.00
IRIX income_statement (quarterly, 2025-09-30) — EBITDA: -1045000.00
IRIX cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 0.00
IRIX cash_flow (quarterly, 2025-09-30) — End Cash Position: 5573000.00
IRIX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -34000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Finished Goods: 3445000.00
IRIX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -1171000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -13000.00
IRIX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1795000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Goodwill: 965000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2029000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 7244000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1062000.00
IRIX income_statement (quarterly, 2025-09-30) — Gross Profit: 4013000.00
IRIX cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
IRIX balance_sheet (quarterly, 2025-09-30) — Inventory: 7301000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2386000.00
IRIX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -13000.00
IRIX cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
IRIX cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
IRIX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 52000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 3705000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 3757000.00
IRIX cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
IRIX cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
IRIX income_statement (quarterly, 2025-09-30) — Net Income: -1573000.00
IRIX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -1573000.00
IRIX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -1573000.00
IRIX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -1573000.00
IRIX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -1573000.00
IRIX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -1573000.00
IRIX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -1573000.00
IRIX cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
IRIX cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
IRIX cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -34000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Net PPE: 1062000.00
IRIX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -13000.00
IRIX cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 0.00
IRIX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2652000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 7208000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 7208000.00
IRIX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -1045000.00
IRIX income_statement (quarterly, 2025-09-30) — Normalized Income: -1573000.00
IRIX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -1158000.00
IRIX cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 0.00
IRIX income_statement (quarterly, 2025-09-30) — Operating Income: -1411000.00
IRIX income_statement (quarterly, 2025-09-30) — Operating Revenue: 10235000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 17049561.00
IRIX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1662000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 2010000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -13000.00
IRIX income_statement (quarterly, 2025-09-30) — Other Gand A: 1795000.00
IRIX income_statement (quarterly, 2025-09-30) — Other Income Expense: -158000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1064000.00
IRIX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 30000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1196000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 315000.00
IRIX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -158000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Other Properties: 1062000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Payables: 4622000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 5214000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 1932000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 6000000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 6000000.00
IRIX cash_flow (quarterly, 2025-09-30) — Preferred Stock Issuance: 0.00
IRIX income_statement (quarterly, 2025-09-30) — Pretax Income: -1569000.00
IRIX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -13000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Raw Materials: 3856000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Receivables: 9530000.00
IRIX income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 8471000.00
IRIX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 366000.00
IRIX cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
IRIX income_statement (quarterly, 2025-09-30) — Research And Development: 972000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -92262000.00
IRIX income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 2657000.00
IRIX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 4452000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Share Issued: 17049561.00
IRIX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 92000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 4681000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -3348000.00
IRIX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
IRIX income_statement (quarterly, 2025-09-30) — Tax Provision: 4000.00
IRIX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
IRIX balance_sheet (quarterly, 2025-09-30) — Total Assets: 28353000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 8386000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Total Debt: 4785000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 4681000.00
IRIX income_statement (quarterly, 2025-09-30) — Total Expenses: 13895000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 23672000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 4287000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 11280000.00
IRIX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -1411000.00
IRIX balance_sheet (quarterly, 2025-09-30) — Working Capital: 11674000.00
IRIX income_statement (annual, 2025-12-31) — +Operating Expense: 21798000.00
IRIX income_statement (quarterly, 2025-12-31) — +Operating Expense: 5492000.00
IRIX income_statement (annual, 2025-12-31) — +Total Revenue: 52675000.00
IRIX income_statement (quarterly, 2025-12-31) — +Total Revenue: 14724000.00
IRIX balance_sheet (annual, 2025-12-31) — Accounts Payable: 5385000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 5385000.00
IRIX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 7613000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 7613000.00
IRIX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -14183000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -14183000.00
IRIX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 91208000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 91208000.00
IRIX balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -112000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -112000.00
IRIX cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 823000.00
IRIX cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
IRIX income_statement (annual, 2025-12-31) — Basic Average Shares: 16934000.00
IRIX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 17187000.00
IRIX income_statement (annual, 2025-12-31) — Basic EPS: -0.26
IRIX income_statement (quarterly, 2025-12-31) — Basic EPS: -0.01
IRIX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 2387000.00
IRIX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 5573000.00
IRIX cash_flow (annual, 2025-12-31) — Capital Expenditure: -143000.00
IRIX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -106000.00
IRIX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 797000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 797000.00
IRIX balance_sheet (annual, 2025-12-31) — Capital Stock: 6174000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 6174000.00
IRIX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 6028000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 6028000.00
IRIX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 6028000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 6028000.00
IRIX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 5964000.00
IRIX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -27000.00
IRIX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -143000.00
IRIX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -106000.00
IRIX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -2115000.00
IRIX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 589000.00
IRIX cash_flow (annual, 2025-12-31) — Change In Account Payable: -1954000.00
IRIX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 976000.00
IRIX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 799000.00
IRIX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 424000.00
IRIX cash_flow (annual, 2025-12-31) — Change In Inventory: 2117000.00
IRIX cash_flow (quarterly, 2025-12-31) — Change In Inventory: -576000.00
IRIX cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 270000.00
IRIX cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 72000.00
IRIX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -571000.00
IRIX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -82000.00
IRIX cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -1565000.00
IRIX cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -455000.00
IRIX cash_flow (annual, 2025-12-31) — Change In Payable: -2446000.00
IRIX cash_flow (quarterly, 2025-12-31) — Change In Payable: 880000.00
IRIX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -1647000.00
IRIX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 1304000.00
IRIX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 162000.00
IRIX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -140000.00
IRIX cash_flow (annual, 2025-12-31) — Change In Receivables: -1151000.00
IRIX cash_flow (quarterly, 2025-12-31) — Change In Receivables: -15000.00
IRIX cash_flow (annual, 2025-12-31) — Change In Working Capital: -2385000.00
IRIX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 108000.00
IRIX cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -1662000.00
IRIX cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -481000.00
IRIX cash_flow (annual, 2025-12-31) — Changes In Cash: 3706000.00
IRIX cash_flow (quarterly, 2025-12-31) — Changes In Cash: 456000.00
IRIX balance_sheet (annual, 2025-12-31) — Common Stock: 174000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Common Stock: 174000.00
IRIX balance_sheet (annual, 2025-12-31) — Common Stock Equity: -1078000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -1078000.00
IRIX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 4000000.00
IRIX income_statement (annual, 2025-12-31) — Cost Of Revenue: 33448000.00
IRIX income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 9247000.00
IRIX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 822000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 822000.00
IRIX balance_sheet (annual, 2025-12-31) — Current Assets: 25252000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Current Assets: 25252000.00
IRIX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 699000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 699000.00
IRIX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 699000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 699000.00
IRIX balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 3677000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 3677000.00
IRIX balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 3677000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 3677000.00
IRIX balance_sheet (annual, 2025-12-31) — Current Liabilities: 13208000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 13208000.00
IRIX cash_flow (annual, 2025-12-31) — Depreciation: 1547000.00
IRIX cash_flow (quarterly, 2025-12-31) — Depreciation: 422000.00
IRIX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1547000.00
IRIX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 422000.00
IRIX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1547000.00
IRIX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 422000.00
IRIX income_statement (annual, 2025-12-31) — Diluted Average Shares: 16934000.00
IRIX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 17187000.00
IRIX income_statement (annual, 2025-12-31) — Diluted EPS: -0.26
IRIX income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.01
IRIX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -4437000.00
IRIX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -184000.00
IRIX balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 1932000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 1932000.00
IRIX balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 117000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 117000.00
IRIX income_statement (annual, 2025-12-31) — EBIT: -2571000.00
IRIX income_statement (quarterly, 2025-12-31) — EBIT: -15000.00
IRIX income_statement (annual, 2025-12-31) — EBITDA: -1024000.00